Top News

GSK Acquires TESARO for $5.1 Billion

January 22, 2019

The acquisition of biopharmaceutical company TESARO is expected to strengthen GSK’s oncology pipeline and commercial footprint.

Lilly to Acquire Loxo Oncology

January 08, 2019

The $8-billion acquisition will broaden Lilly's oncology portfolio in precision medicines and treatments that target cancers caused by specific gene abnormalities.

Bristol-Myers Squibb to Acquire Celgene in $74-Billion Deal

January 03, 2019

Merger cites combined strengths in oncology, immunology and inflammation, and cardiovascular disease.

Critical FDA Functions Continue as US Government Shutdown Hits the One-Week Mark

December 29, 2018

Core functions and those funded by FY 2018 user fees are continuing, and 59% of the Agency’s staffers are being retained.

GSK and Pfizer Merge Consumer Healthcare Businesses

December 19, 2018

The proposed $12.7-billion deal includes the spinoff of GSK and Pfizer consumer brands to a new UK-listed company.

Takeda, Shire Shareholders Approve Proposed Acquisition

December 12, 2018

The $62-billion acquisition of Shire by Takeda Pharmaceutical was approved by both sets of shareholders.

FDA Answers Data Integrity Questions

December 12, 2018

Pharmaceutical Technology's In the Lab eNewsletter

New FDA guidance developed to identify lapses in data integrity and promote best practices.